Harte-Hanks, Inc. (NYSE:HHS), saw Director Christopher M. Harte increase his position with the company. Harte acquired 6,954 shares of common stock at an average of $7.19 per share. Following this transaction, Harte now directly holds 96,681 shares while indirectly holding 769,389 shares in Harte-Hanks, Inc. (NYSE:HHS). This is not the first time this year that Harte has risen his stake in the company as back in April he purchased 1,782 shares of common stock at an average of $8.84 per share.
As well, three major hedge funds have shown movement in their holdings with the $450.13 million market cap marketing and shopper advertisement company. Chuck Royce‘s Royce & Associates rose it’s activity by 6168% over the last quarter, now having 726,391 shares worth about $6.4 million; Arrowstreet Capital, the hedge fund run by Peter Rathjens, Bruce Clarke and John Campbell, lowered it’s involvement by 29%, and now has 204,421 shares worth nearly $2 million; and Jim Simon‘s Renaissance Technologies saw a 247% rise in it’s exposure to Harte-Hanks, Inc. (NYSE:HHS), now holding 149,126 shares worth approximately $1.3 million.
Disclosure: The author, Daniel Forstein, holds no positions in any stocks mentioned.
